BioTek Readers Receive Promega DLReady™ Certification
News Aug 07, 2015
Several BioTek readers have just received official Promega DLReady™ certifications. Synergy™ Neo2, Cytation™ 5, Cytation 3, Synergy H1, Synergy 2 and Synergy HTX have all now met the stringent acceptance criteria.
Promega’s Dual-Luciferase© Reporter System together with BioTek microplate readers demonstrate both companies’ common commitment to maximizing the success of life science researchers.
BioTek’s patented Hybrid and Multi-Mode microplate readers offer flexibility and ease of use over a broad range of applications. In the Hybrid reader line, Synergy H1 offers an unbeatable price / performance ratio, while Synergy Neo2 covers the broadest range of applications.
In addition, Cytation Multi-Mode Readers are upgradable to add digital microscopy capability. BioTek’s multi-mode readers offer configurability to provide the most value for laboratory budgets. Synergy 2 and Synergy HTX offer modular features and outstanding specifications for performance and economy.
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE